Oral News and Research

RSS

First long-term study to evaluate repeated treatment with BoNTA for post-stroke spasticity

New research shows that repeated treatments of botulinum toxin type A (BoNTA) over one year after a stroke can improve muscle tone and reduce pain in the arms and hands, making it easier for patients to dress themselves and perform personal hygiene.

30 Oct 2005

Type 2 diabetes and depression can be a fatal mix

Patients whose type 2 diabetes was accompanied by minor or major depression had higher mortality rates, compared to patients with type 2 diabetes alone, over the three-year period of a recent study in Washington state.

27 Oct 2005

Intravenous lidocaine and oral derivatives relieve pain from damage to the nervous system

Lidocaine and similar local anesthetics are effective for treating pain that emanates from damaged nerves, according to a systematic review of current evidence.

23 Oct 2005

Intensity modulated radiation therapy (IMRT) for head and neck cancer

Results from a University of Pittsburgh study evaluating intensity modulated radiation therapy (IMRT) for head and neck cancer determined the ideal doses for lessening treatment side effects. The findings were presented today at the 47th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Denver.

18 Oct 2005

Possible new combination treatment regimen for patients with head and neck cancers who develop a second tumor

Few treatment options exist for patients with head and neck cancers who develop a second tumor or whose disease recurs in an area that has previously received radiation. Data from an international study reveal a possible new combination treatment regimen that offers a significant survival advantage for many of these patients.

18 Oct 2005

Evidence is mounting to link toxoplasmosis with schizophrenia

Keep pet cats inside, stop feeding strays, cook meat sufficiently and reconsider the way the veterinary profession and public health agencies think - and teach - about the zoonotic pathogen Toxoplasma gondii.

18 Oct 2005

Breath-analysis testing may prove to be an effective method for detecting the damaging lung-bacteria growth seen in cystic fibrosis

By using a chemical analysis method developed for air-pollution testing, UCI chemists and pediatricians have found that people with cystic fibrosis exhale higher concentrations of sulfur compounds from their lungs than do people who don't have the disease.

17 Oct 2005

dnaJP1 - novel drug for the treatment of rheumatoid arthritis

Researchers at the University of California, San Diego (UCSD) School of Medicine have announced successful completion of Phase II clinical trials of a novel drug for the treatment of rheumatoid arthritis (RA), one that works without suppressing the patient's immune system.

16 Oct 2005

Actos reduces the combined risk of non-fatal heart attacks, strokes in patients with type-2 diabetes

A study published in The Lancet shows that Takeda's Actos (pioglitazone HCl), an oral glucose lowering medication, significantly reduces the combined risk of non-fatal heart attacks, strokes and deaths by an additional 16% on top of standard medication

10 Oct 2005

Long-term use of NSAIDs cuts the risk for oral cancer in smokers by half but increases risk of cardiovascular problems

An analysis of 20 years of data on the health of over 900 adults has found that long-term use of traditional nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen, cuts the risk for oral cancer in smokers by half.

9 Oct 2005

Cancer incidence among women has increased slightly

Overall rates of cancer death for both men and women have declined in the United States, and cancer incidence has remained stable among men. However, overall cancer incidence among women has increased slightly, according to a special article that appears in the October 5 issue of the Journal of the National Cancer Institute.

4 Oct 2005

Clinical trials of daily oral antiretroviral dosing as pre-exposure prophylaxis

Writing in the journal Science, an international team of researchers, clinicians and others explains that a promising, relatively new approach is for people not infected but at high risk to take drugs that might prevent them from contracting HIV. But debate over the particulars of the strategy has slowed progress.

3 Oct 2005

Salivary antimicrobial peptide expression and dental caries experience in children

A study comparing antimicrobial peptides, or AMPs, a group of small proteins that occur naturally in human saliva and act like antibiotics against oral bacteria, could lead to new ways to screen children for risk of tooth decay and protect them against this common, chronic problem.

28 Sep 2005

Governments considering reclassifying some drugs from prescription to over-the-counter status

Governments in several countries with public Pharmacare and in a few provinces in Canada are considering reclassifying some drugs from prescription to over-the-counter status. In a Canadian Medical Association Journal essay, Lynd and colleagues comment on the economic effects of such changes.

27 Sep 2005

Women with postmenopausal osteoporosis prefer once monthly to weekly treatment

Over 70% of postmenopausal women with Osteoporosis who expressed a preference, preferred once-monthly Bonviva, finding it more convenient than a once-weekly treatment. This is according to new data presented at the 27th Annual Meeting of the American Society for Bone Mineral Research (ASBMR).

26 Sep 2005

Powerful orthopedic repair compound

Bone Solutions, Inc. of Dallas, TX, announced at a Dow Jones Lifescience Conference that it had successfully tested its magnesium-based orthopedic adhesive technology in multiple studies to prove full biocompatibility for injection into animals and humans, with powerful mechanical properties that gave its unusual strength and performance beyond current orthopedic industry products.

26 Sep 2005

Potential oral drug for rheumatoid arthritis

A potential oral drug for rheumatoid arthritis (RA) may encourage women to treat their condition earlier rather than later because it is less arduous than currently available treatments. Early treatment is important because RA most often develops between the ages of 35 and 50 and is two- to three times more prevalent in women.

26 Sep 2005

Implant-placed overdentures make life more pleasurable

The enticing aroma of a thick, juicy steak was a temptation Marvin Goodwin oftentimes avoided because his dentures made the meat difficult to chew. Now that he's had implants placed to support his denture, he is no longer cautious of the foods he eats.

26 Sep 2005

Drug that blocks acid buildup inside cells revs up the immune response to vaccines

Reporting in the current issue of The Journal of Experimental Medicine, Vincenzo Barnaba and his team at the University of Rome show that people receiving booster shots against hepatitis B virus developed more robust immune responses if given a widely used anti-malaria drug called chloroquine.

21 Sep 2005

Green tea may protect the brain against Alzheimer's disease

Researchers at the University of South Florida (USF) have found that green tea may offer another potential health benefit - protecting the brain against the ravages of Alzheimer's disease.

20 Sep 2005

Oral News and Research

First long-term study to evaluate repeated treatment with BoNTA for post-stroke spasticity

Type 2 diabetes and depression can be a fatal mix

Intravenous lidocaine and oral derivatives relieve pain from damage to the nervous system

Intensity modulated radiation therapy (IMRT) for head and neck cancer

Possible new combination treatment regimen for patients with head and neck cancers who develop a second tumor

Evidence is mounting to link toxoplasmosis with schizophrenia

Breath-analysis testing may prove to be an effective method for detecting the damaging lung-bacteria growth seen in cystic fibrosis

dnaJP1 - novel drug for the treatment of rheumatoid arthritis

Actos reduces the combined risk of non-fatal heart attacks, strokes in patients with type-2 diabetes

Long-term use of NSAIDs cuts the risk for oral cancer in smokers by half but increases risk of cardiovascular problems

Cancer incidence among women has increased slightly

Clinical trials of daily oral antiretroviral dosing as pre-exposure prophylaxis

Salivary antimicrobial peptide expression and dental caries experience in children

Governments considering reclassifying some drugs from prescription to over-the-counter status

Women with postmenopausal osteoporosis prefer once monthly to weekly treatment

Powerful orthopedic repair compound

Potential oral drug for rheumatoid arthritis

Implant-placed overdentures make life more pleasurable

Drug that blocks acid buildup inside cells revs up the immune response to vaccines

Green tea may protect the brain against Alzheimer's disease

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News